Induced elevation of blood pressure in the acute phase of ischemic stroke in humans.

To the Editor: Blood pressure is often elevated in the acute phase of stroke. Possible reasons are previous hypertension, a pathophysiological response to ensure perfusion in the ischemic penumbra, or a reaction to the stress of hospitalization. The course of blood pressure following an acute stroke has been extensively studied and shows a spontaneous decline during the first week.1 2 3 4 5 Decreasing the blood pressure in the acute phase of stroke can have a deleterious effect on outcome.6 7 The consensus is not to treat high blood pressure during the first week, except for a consistently elevated systolic blood pressure >250 mm Hg or diastolic blood pressure >140 mm Hg.8 9 The safety and efficacy of increasing blood pressure is completely unknown. The rationale for this therapy is that it may help to restore the blood flow to the ischemic area of which the perfusion is passively dependent on the systemic blood pressure because of the loss of local autoregulation, or it may induce dilatation of the leptomeningeal collateral circulation in case of an embolic occlusion. Early reports in humans10 11 and recent experimental work12 13 have shown a beneficial effect on outcome of treatment with induced hypertension.14 15 In animal stroke models, diaspirin cross-linked hemoglobin (DCLHb), a purified cell-free human oxygen-carrying …

[1]  D. J. Cole,et al.  Delayed institution of hypertension during focal cerebral ischemia: effect on brain edema , 2004, Acta Neuropathologica.

[2]  M. Kaste,et al.  Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. , 1999, Stroke.

[3]  P. Koudstaal,et al.  Effect of diaspirin cross‐linked hemoglobin on endothelin‐1 and blood pressure in acute ischemic stroke in man , 1998, Journal of hypertension.

[4]  B. Tranmer,et al.  Induced hypervolemia and inotropic support for acute cerebral arterial insufficiency: an underused therapy. , 1998, Surgical neurology.

[5]  F. Buonanno,et al.  Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. , 1997, Stroke.

[6]  D. J. Cole,et al.  Alpha-alpha diaspirin crosslinked hemoglobin, nitric oxide, and cerebral ischemic injury in rats. , 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

[7]  R. Herd,et al.  White coat effects , 1995, BMJ.

[8]  K. Burhop,et al.  Diaspirin Cross‐linked Hemoglobin Improves Neurological Outcome Following Reversible but Not Irreversible CNS Ischemia in Rabbits , 1994, Stroke.

[9]  M. Kaste,et al.  A Randomized, Double‐blind, Placebo‐Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke , 1994, Stroke.

[10]  D. J. Cole,et al.  Induced hypertension during restoration of flow after temporary middle cerebral artery occlusion in the rat: effect on neuronal injury and edema. , 1991, Surgical neurology.

[11]  K. Asplund,et al.  Factors influencing admission blood pressure levels in patients with acute stroke. , 1991, Stroke.

[12]  K. Asplund,et al.  Course of Blood Pressure in Different Subsets of Patients after Acute Stroke , 1991 .

[13]  U. de Faire,et al.  Blood pressure course in patients with acute stroke and matched controls. , 1986, Stroke.

[14]  J. Zivin,et al.  Hypertension in acute ischemic strokes. Not to treat. , 1985, Archives of neurology.

[15]  V. Hachinski Hypertension in acute ischemic strokes. , 1985, Archives of neurology.

[16]  D. W. Beck,et al.  Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1982, Neurosurgery.

[17]  J. D. Wallace,et al.  Blood pressure after stroke. , 1981, JAMA.

[18]  G. Wise,et al.  The Treatment of Brain Ischemia With Vasopressor Drugs , 1972, Stroke.

[19]  G. Wise Vasopressor-drug therapy for complications of cerebral arteriography. , 1970, The New England journal of medicine.